Addex Pharmaceuticals (SWISS: ADXN), the allosteric modulation company, announced the start of a Phase IIb trial of ADX10059 monotherapy in patients with gastroesophageal reflux disease (GERD), the cause of heartburn and other symptoms. ADX10059 is a first-in- class reflux inhibitor that works by reducing activation of the metabotropic glutamate receptor 5 (mGluR5) through negative allosteric modulation (NAM). Read more ...
The HIV/AIDS Surveillance Supplemental Report is published by the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta, Georgia. Read more ...
Friday, December 19, 2008
Annual Congress European Association Of Urology: Highlights In Stockholm
The 24th Annual Congress of the European Association of Urology (EAU) will be held from 17 to 21 March 2009 in the Stockholm International Fairs (SE). The scientific programme covers the whole range of the urological field. From 'Bladder Unlimited' to 'The art of ageing'; it will all be discussed at the congress. The traditional half-day joint sessions with regional urological groups are extended to a full-day event called EAU International Day - Urology Beyond Europe. More at...
Family and friends of a 75-year-old California grandmother beaten and kidnapped from her home last week might have known of the crime within moments if a device patented by an Indiana University researcher had been in use. If Sandy Vinge had been using The Portal Monitor developed by Indiana University professor L. More at...
Sorafenib significantly increases overall survival in Asian-Pacific patients with advanced hepatocellular carcinoma - a group where surgical treatments can be limited - according to findings of a phase III trial reported in an Article published early Online and in the January edition of The Lancet Oncology. Hepatocellular carcinoma is the third most common cause of cancer-related death and is a particular challenge in the Asia-Pacific region, where 75% of cases occur. More at...
Elsevier, world-leading publisher of scientific, technical, and medical information products and services, is pleased to announce that, beginning in January 2009, the internationally respected Journal of Pain and Symptom Management (JPSM) (http://www.jpsmjournal.com) will be the official journal of the American Academy of Hospice and Palliative Medicine (AAHPM). More at...
Family and friends of a 75-year-old California grandmother beaten and kidnapped from her home last week might have known of the crime within moments if a device patented by an Indiana University researcher had been in use. If Sandy Vinge had been using The Portal Monitor developed by Indiana University professor L. More at...
Sorafenib significantly increases overall survival in Asian-Pacific patients with advanced hepatocellular carcinoma - a group where surgical treatments can be limited - according to findings of a phase III trial reported in an Article published early Online and in the January edition of The Lancet Oncology. Hepatocellular carcinoma is the third most common cause of cancer-related death and is a particular challenge in the Asia-Pacific region, where 75% of cases occur. More at...
Elsevier, world-leading publisher of scientific, technical, and medical information products and services, is pleased to announce that, beginning in January 2009, the internationally respected Journal of Pain and Symptom Management (JPSM) (http://www.jpsmjournal.com) will be the official journal of the American Academy of Hospice and Palliative Medicine (AAHPM). More at...
Subscribe to:
Posts (Atom)
